This company listing is no longer active
Albireo Pharma Dirección
Dirección controles de criterios 2/4
Información clave
Ron Cooper
Chief Executive Officer (CEO)
US$6.0m
Compensación total
Porcentaje del salario del CEO | 9.8% |
Permanencia del CEO | 7.7yrs |
Participación del CEO | 0.2% |
Permanencia media de la dirección | 4.2yrs |
Promedio de permanencia en la Junta Directiva | 5.5yrs |
Actualizaciones recientes de la dirección
Recent updates
Análisis de compensación del CEO
Fecha | Compensación total | Salario | Ingresos de la empresa |
---|---|---|---|
Sep 30 2022 | n/a | n/a | -US$131m |
Jun 30 2022 | n/a | n/a | -US$36m |
Mar 31 2022 | n/a | n/a | -US$33m |
Dec 31 2021 | US$6m | US$590k | -US$34m |
Sep 30 2021 | n/a | n/a | -US$48m |
Jun 30 2021 | n/a | n/a | -US$136m |
Mar 31 2021 | n/a | n/a | -US$120m |
Dec 31 2020 | US$3m | US$570k | -US$108m |
Sep 30 2020 | n/a | n/a | -US$90m |
Jun 30 2020 | n/a | n/a | -US$82m |
Mar 31 2020 | n/a | n/a | -US$78m |
Dec 31 2019 | US$3m | US$551k | -US$63m |
Sep 30 2019 | n/a | n/a | -US$71m |
Jun 30 2019 | n/a | n/a | -US$63m |
Mar 31 2019 | n/a | n/a | -US$61m |
Dec 31 2018 | US$4m | US$530k | -US$46m |
Sep 30 2018 | n/a | n/a | -US$35m |
Jun 30 2018 | n/a | n/a | -US$28m |
Mar 31 2018 | n/a | n/a | -US$19m |
Dec 31 2017 | US$2m | US$460k | -US$24m |
Sep 30 2017 | n/a | n/a | -US$31m |
Jun 30 2017 | n/a | n/a | -US$28m |
Mar 31 2017 | n/a | n/a | -US$20m |
Dec 31 2016 | US$4m | US$400k | -US$16m |
Compensación vs. Mercado: Ron's total compensation ($USD6.04M) is above average for companies of similar size in the German market ($USD1.12M).
Compensación vs. Ingresos: Ron's compensation has increased whilst the company is unprofitable.
CEO
Ron Cooper (59 yo)
7.7yrs
Permanencia
US$6,041,334
Compensación
Mr. Ronald H. W. Cooper, also known as Ron, serves as Independent Director at Generation Bio Co. since March 2021. He has been the Chief Executive Officer and President of Albireo Pharma Inc. since July 20...
Equipo directivo
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
CEO, President & Director | 7.7yrs | US$6.04m | 0.16% $ 1.4m | |
CFO & Treasurer | 4.4yrs | US$1.71m | 0.066% $ 572.3k | |
Chief Regulatory Officer | 6.3yrs | US$1.73m | 0.018% $ 152.3k | |
Co-Founder & VP of Development | no data | sin datos | sin datos | |
Chief Scientific Officer | 15.2yrs | US$1.40m | 0.17% $ 1.5m | |
Chief Technology Officer | 1.9yrs | sin datos | sin datos | |
Chief Legal Officer | 4.8yrs | sin datos | 0.016% $ 137.3k | |
Chief Human Resources Officer | 3.3yrs | sin datos | 0.027% $ 230.9k | |
VP & Global Project Head | no data | sin datos | sin datos | |
Chief Commercial Officer | 4yrs | US$1.96m | 0.11% $ 926.5k | |
Chief Business Officer | 1.3yrs | sin datos | sin datos | |
Chief Medical Officer | less than a year | sin datos | sin datos |
4.2yrs
Permanencia media
58.5yo
Promedio de edad
Equipo directivo experimentado: BDQM's management team is considered experienced (4.2 years average tenure).
Miembros de la Junta
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
CEO, President & Director | 7.5yrs | US$6.04m | 0.16% $ 1.4m | |
Independent Chairman of the Board | 15.1yrs | US$282.44k | 0.27% $ 2.3m | |
Independent Director | 6.3yrs | US$266.82k | 0.14% $ 1.3m | |
Independent Director | 7.4yrs | US$264.94k | 0.13% $ 1.1m | |
Director | less than a year | sin datos | sin datos | |
Independent Director | less than a year | sin datos | sin datos | |
Independent Director | 4.8yrs | US$249.94k | 0.14% $ 1.2m | |
Director | less than a year | sin datos | sin datos |
5.5yrs
Permanencia media
59yo
Promedio de edad
Junta con experiencia: BDQM's board of directors are considered experienced (5.5 years average tenure).